financetom
MS
financetom
/
Financials
/
MS
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Morgan StanleyMS
123.44USD
+2.94 (2.44%)
Dec 20, 2024, 4:00 PM - At close
123.70USD
+0.26 (0.21%)
Dec 20, 2024, 7:20 PM EST - Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
198.87B
Revenue (ttm)
58.28B
Net Income (ttm)
10.62B
Shares Out
1.61B
EPS (ttm)
6.57
PE Ratio
18.80
Forward PE
15.89
Dividend
$3.70 (3.00%)
Ex-Dividend Date
Oct 31, 2024
Volume
6,369,299
Open
121.20
Previous Close
120.50
Day's Range
120.53 - 124.54
52-Week Range
83.09 - 136.24
Beta
1.35
Analysts
Buy
Price Target
123.00 (-0.36%)
Earnings Date
Jan 16, 2025
Description >

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia.

It operates through Institutional Securities, Wealth Management, and Investment Management segments. The Institutional Securities segment offers capital raising and financial advisory services, including services related to the underwriting of debt, equity, and other securities, as well as advice on mergers and acquisitions, restructurings, real estate, and project finance.

This segment also provides equity and fixed income products comprising sales, financing, prime brokerage, and market-making services; foreign exchange and commodities; corporate and commercial real estate loans, commercial mortgage and secured lending facilities, and financing for sales and trading customers, and asset-backed and mortgage lending; and wealth management services, investment, and research services.

The Wealth Management segment offers financial advisor-led brokerage, custody, administrative, and investment advisory services; self-directed brokerage services; financial and wealth planning services; workplace services, including stock plan administration; annuity and insurance products; securities-based lending, residential real estate loans, and other lending products; banking; and retirement plan services to individual investors and small to medium-sized businesses and institutions.

The Investment Management segment provides equity, fixed income, alternatives and solutions, and liquidity and overlay services to benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors, corporations, and individuals through institutional and intermediary channels.

Morgan Stanley was founded in 1924 and is headquartered in New York, New York.

Latest News >
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
Market Chatter: Exxon Mobil to Establish Tech Hub in Houston, Close New Jersey, Ontario Campuses
May 7, 2024
12:28 PM EDT, 05/07/2024 (MT Newswires) -- Exxon Mobil ( XOM ) plans to set up a single North American research and technology hub at its Houston headquarters and close campuses in Clinton, New Jersey, and Sarnia in Ontario, Bloomberg reported Tuesday, citing a company spokeswoman. The majority of 700 workers affected by the closures are being offered roles in...
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
Brazil meatpackers join forces to resume operations amid floods, meat lobby says
May 7, 2024
SAO PAULO, May 7 (Reuters) - Competing Brazilian meatpackers have joined forces to circumvent problems caused by heavy flooding in Rio Grande do Sul state, where torrential rains severely disrupted operations, a local meat lobby said on Tuesday. Jose Ribas, who presides over Sindicarne in the neighboring state of Santa Catarina, said local meatpackers were working in partnership to overcome...
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates
May 7, 2024
12:24 PM EDT, 05/07/2024 (MT Newswires) -- Ligand Pharmaceuticals ( LGND ) and Agenus ( AGEN ) said Tuesday they have signed a royalty financing agreement to support the clinical development of Agenus' ( AGEN ) botensilimab and balstilimab, including a confirmatory phase 3 trial in metastatic, relapsed or refractory colorectal cancer. Under the terms of the agreement, Ligand will...
Campari has taste for more M&A after Courvoisier deal, new CEO says
Campari has taste for more M&A after Courvoisier deal, new CEO says
May 7, 2024
MILAN, May 7 (Reuters) - Campari will seek further M&A opportunties after completing the buyout of French cognac house Courvoisier, the new head of the Italian drinks group said on Tuesday. The group completed the 1.22-billion euro ($1.3 billion)acquisition of Courvoisier last week, earlier than expected by analysts. It was the largest ever deal for Campari, whose brands include the...
Copyright 2023-2024 - www.financetom.com All Rights Reserved